American Capital Advisory’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
SIMG
CC
FFM
PCM
FMI
OIAM
American Capital Advisory's DXCM Position: Q2 2026 in Review
American Capital Advisory increased its DexCom (DXCM) stake by 0.75% in Q2 2026, buying an estimated $133 and bringing the position to 269 shares worth $18.1K. The position accounts for 0.01% of the portfolio, ranked #310.
American Capital Advisory first reported a position in DXCM in Q4 2023 and has held it in 9 quarters since. The position peaked at $23.6K in Q2 2024. 327 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- American Capital Advisory held 269 shares of DexCom worth $18.1K as of Q2 2026.
- American Capital Advisory bought 2 DexCom shares in Q2 2026, an estimated $133.
- DexCom made up 0.01% of American Capital Advisory's portfolio in Q2 2026, its #310 holding.
- American Capital Advisory first reported a position in DexCom in Q4 2023 and has held it in 9 quarters since.
- American Capital Advisory's DexCom position peaked at $23.6K in Q2 2024.
- 327 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.